Trial Profile
Pregnancy outcomes following exposure to onabotulinumtoxinA
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Hyperhidrosis; Migraine; Movement disorders; Muscle spasticity; Neurogenic bladder; Skin wrinkles
- Focus Adverse reactions
- Sponsors Allergan
- 09 Dec 2015 New trial record
- 04 Dec 2015 Results published in the Pharmacoepidemiology and Drug Safety